These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 15288306)
1. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae. Rzeszutek M; Wierzbowski A; Hoban DJ; Conly J; Bishai W; Zhanel GG Int J Antimicrob Agents; 2004 Aug; 24(2):95-104. PubMed ID: 15288306 [TBL] [Abstract][Full Text] [Related]
2. The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative. Nuermberger E; Bishai WR Clin Infect Dis; 2004 Jan; 38(1):99-103. PubMed ID: 14679455 [TBL] [Abstract][Full Text] [Related]
3. Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study. Schentag JJ; Klugman KP; Yu VL; Adelman MH; Wilton GJ; Chiou CC; Patel M; Lavin B; Paladino JA Int J Antimicrob Agents; 2007 Sep; 30(3):264-9. PubMed ID: 17587549 [TBL] [Abstract][Full Text] [Related]
4. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P; Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184 [TBL] [Abstract][Full Text] [Related]
5. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes? Rothermel CD Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368 [TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital. Bonofiglio L; Ojeda MI; de Mier C; Vay C; Famiglietti A; Gutkind G; Mollerach M Int J Antimicrob Agents; 2005 Mar; 25(3):260-3. PubMed ID: 15737523 [TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children. Chiba N; Kobayashi R; Hasegawa K; Morozumi M; Nakayama E; Tajima T; Iwata S; Ubukata K; J Antimicrob Chemother; 2005 Oct; 56(4):756-60. PubMed ID: 16131518 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan. Ishida T; Maniwa K; Kagioka H; Hirabayashi M; Onaru K; Tomioka H; Hayashi M; Tomii K; Gohma I; Ito Y; Hirai T; Ito I; Mishima M Respirology; 2008 Mar; 13(2):240-6. PubMed ID: 18339022 [TBL] [Abstract][Full Text] [Related]
9. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005. Wolter N; von Gottberg A; du Plessis M; de Gouveia L; Klugman KP; Int J Antimicrob Agents; 2008 Jul; 32(1):62-7. PubMed ID: 18339522 [TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. Feldman C J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia. Fogarty C; Torres A; Choudhri S; Haverstock D; Herrington J; Ambler J Int J Clin Pract; 2005 Nov; 59(11):1253-9. PubMed ID: 16236076 [TBL] [Abstract][Full Text] [Related]
13. In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure. Jacobs MR Clin Infect Dis; 2002 Sep; 35(5):565-9. PubMed ID: 12173130 [No Abstract] [Full Text] [Related]
14. Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era. Daikos GL; Koutsolioutsou A; Tsiodras S; Theodoridou M; Koutouzis EI; Charissiadou A; Pangalis A; Michos AG; Chaidopoulou F; Braoudaki M; Syriopoulou VP Diagn Microbiol Infect Dis; 2008 Apr; 60(4):393-8. PubMed ID: 18077121 [TBL] [Abstract][Full Text] [Related]
15. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004). Farrell DJ; Couturier C; Hryniewicz W Int J Antimicrob Agents; 2008 Mar; 31(3):245-9. PubMed ID: 18178388 [TBL] [Abstract][Full Text] [Related]
16. Macrolide resistance among invasive Streptococcus pneumoniae in Slovenia. Kastrin T; Gubina M; Paragi M; Kolman J; Cizman M; Kraigher A; Ribic H; Sadowy E; Hryniewicz W J Antimicrob Chemother; 2008 Sep; 62(3):628-9. PubMed ID: 18474511 [No Abstract] [Full Text] [Related]
17. [No obvious difference in Streptococcus pneumoniae antibiotic resistance profiles--isolates from HIV-positive and HIV-negative patients]. Stephan C; Just-Nübling G; Franck S; Bickel M; Shah PM; Babacan E; Staszewski S Med Klin (Munich); 2008 Feb; 103(2):69-74. PubMed ID: 18270662 [TBL] [Abstract][Full Text] [Related]
18. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Kelley MA; Weber DJ; Gilligan P; Cohen MS Clin Infect Dis; 2000 Oct; 31(4):1008-11. PubMed ID: 11049784 [TBL] [Abstract][Full Text] [Related]
19. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Fuller JD; Low DE Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772 [TBL] [Abstract][Full Text] [Related]
20. Macrolide and ketolide resistance with Streptococcus pneumoniae. Doern GV Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]